Annual EBITDA
$3.26B$400.00M+13.97%
Summary
- Current Value
- As of today, CAH annual EBITDA is $3.26B, up +13.97% on
- Historical Performance
- CAH annual EBITDA is up +36.19% over the past 3 years, up +20.94% over the past 5 years
- All-Time High Comparison
- CAH annual EBITDA is currently -8.24% below its historical high of $3.56B set on
- 3-Year Low Comparison
- CAH annual EBITDA is +36.19% above its 3-year low of $2.40B reached on an earlier date
- Sector Comparison
- CAH annual EBITDA is higher than 96.73% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.26B | +14.0% | +36.2% | +20.9% | +100.7% | |
| Quarterly EBITDA | $1.20B | +28.4% | +69.1% | +54.0% | +93.1% | |
| TTM EBITDA | $4.18B | +32.5% | +77.6% | +53.6% | +115.7% | |
| Price | $200.37 | +30.2% | +133.2% | +258.2% | +342.8% | |
| PE Ratio | 30.64 | +27.5% | -37.8% | +113.8% | +87.5% | |
| Annual Revenue | $222.58B | -1.9% | +22.7% | +45.5% | +126.0% | |
| Annual EPS | $6.45 | +87.0% | +292.9% | +151.1% | +263.0% | |
| $2.79B | +29.4% | +66.5% | +56.4% | +101.7% | ||
| Annual Net Income | $1.57B | +83.9% | +268.4% | +142.5% | +167.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.26B | at high | |
| 5Y | $3.26B | at high | |
| All | $3.56B | -8.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.40B | N/A | +36.2% |
| 5Y | $2.40B | +36.2% | |
| All | $4.10M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of CAH?
As of today, CAH annual EBITDA is $3.26B
What is 1-year change in CAH annual EBITDA?
CAH annual EBITDA is up +13.97% year-over-year
What is 3-year change in CAH annual EBITDA?
CAH annual EBITDA is up +36.19% over the past 3 years
How far is CAH annual EBITDA from its all-time high?
CAH annual EBITDA is currently -8.24% below its historical high of $3.56B set on June 30, 2018
How does CAH annual EBITDA rank versus sector peers?
CAH annual EBITDA is higher than 96.73% of companies in Healthcare sector
When is CAH next annual earnings release?
The next annual earnings release for CAH is on
Quarterly EBITDA
$1.20B$161.00M+15.44%
Summary
- Current Value
- As of today, CAH quarterly EBITDA is $1.20B, up +15.44% on
- Historical Performance
- CAH quarterly EBITDA is up +28.36% year-over-year, up +69.10% over the past 3 years
- All-Time High Comparison
- CAH quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH quarterly EBITDA is +81.05% above its 3-year low of $665.00M reached on
- Sector Comparison
- CAH quarterly EBITDA is higher than 97.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.20B | +15.4% | +28.4% | +69.1% | +54.0% | |
| Annual EBITDA | $3.26B | – | +14.0% | +36.2% | +20.9% | |
| TTM EBITDA | $4.18B | +6.8% | +32.5% | +77.6% | +53.6% | |
| Price | $200.37 | -10.1% | +30.2% | +133.2% | +258.2% | |
| PE Ratio | 30.64 | -4.4% | +27.5% | -37.8% | +113.8% | |
| Quarterly Revenue | $60.94B | -7.1% | +11.1% | +20.7% | +55.2% | |
| Quarterly EPS | $1.69 | -14.2% | -19.5% | +26.4% | +317.7% | |
| $956.00M | +18.2% | +30.8% | +78.0% | +64.0% | ||
| Quarterly Net Income | $380.00M | -19.3% | -25.2% | +9.5% | +216.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.20B | at high | |
| 3Y | $1.20B | at high | |
| 5Y | $1.20B | at high | |
| All | $1.20B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $927.00M | +29.9% | |
| 3Y | $665.00M | +81.0% | |
| 5Y | $435.00M | +176.8% | |
| All | -$484.00M | +348.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CAH?
As of today, CAH quarterly EBITDA is $1.20B
What is CAH quarterly EBITDA most recent change?
CAH quarterly EBITDA was up +15.44% on March 31, 2026
What is 1-year change in CAH quarterly EBITDA?
CAH quarterly EBITDA is up +28.36% year-over-year
How far is CAH quarterly EBITDA from its all-time high?
CAH quarterly EBITDA is currently at its all-time high
How does CAH quarterly EBITDA rank versus sector peers?
CAH quarterly EBITDA is higher than 97.23% of companies in Healthcare sector
When is CAH next earnings release?
The next earnings release for CAH is on
TTM EBITDA
$4.18B$266.00M+6.80%
Summary
- Current Value
- As of today, CAH TTM EBITDA is $4.18B, up +6.80% on
- Historical Performance
- CAH TTM EBITDA is up +32.51% year-over-year, up +77.56% over the past 3 years
- All-Time High Comparison
- CAH TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH TTM EBITDA is +77.56% above its 3-year low of $2.35B reached on an earlier date
- Sector Comparison
- CAH TTM EBITDA is higher than 97.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.18B | +6.8% | +32.5% | +77.6% | +53.6% | |
| Annual EBITDA | $3.26B | – | +14.0% | +36.2% | +20.9% | |
| Quarterly EBITDA | $1.20B | +15.4% | +28.4% | +69.1% | +54.0% | |
| Price | $200.37 | -10.1% | +30.2% | +133.2% | +258.2% | |
| PE Ratio | 30.64 | -4.4% | +27.5% | -37.8% | +113.8% | |
| TTM Revenue | $250.74B | +2.5% | +12.8% | +26.2% | +60.1% | |
| TTM EPS | $6.54 | -5.9% | +2.1% | +275.0% | +67.5% | |
| $3.25B | +7.4% | +36.4% | +96.3% | +72.3% | ||
| TTM Net Income | $1.55B | -7.6% | -0.7% | +232.9% | +34.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.18B | at high | |
| 3Y | $4.18B | at high | |
| 5Y | $4.18B | at high | |
| All | $4.18B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.15B | N/A | +32.5% |
| 3Y | $2.35B | N/A | +77.6% |
| 5Y | $2.27B | +84.2% | |
| All | -$96.20M | +4443.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CAH?
As of today, CAH TTM EBITDA is $4.18B
What is CAH TTM EBITDA most recent change?
CAH TTM EBITDA was up +6.80% on March 31, 2026
What is 1-year change in CAH TTM EBITDA?
CAH TTM EBITDA is up +32.51% year-over-year
How far is CAH TTM EBITDA from its all-time high?
CAH TTM EBITDA is currently at its all-time high
How does CAH TTM EBITDA rank versus sector peers?
CAH TTM EBITDA is higher than 97.05% of companies in Healthcare sector
When is CAH next earnings release?
The next earnings release for CAH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CAH Official Website www.cardinalhealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/721371/000072137125000079/0000721371-25-000079-index.htm
- CAH Profile on Yahoo Finance finance.yahoo.com/quote/CAH
- CAH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cah